Market revenue in 2023 | USD 249.9 million |
Market revenue in 2030 | USD 314.0 million |
Growth rate | 3.3% (CAGR from 2023 to 2030) |
Largest segment | Oral |
Fastest growing segment | Enteral |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Enteral, Parenteral |
Key market players worldwide | Abbott Laboratories, Pfizer Inc, Bayer AG, Nestle SA, GlaxoSmithKline, Baxter International Inc, Otsuka Holdings Co Ltd, Reckitt Benckiser Group PLC, Danone SA, Victus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical nutrition for cancer care market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 47.9% in 2023. Horizon Databook has segmented the UK clinical nutrition for cancer care market based on oral, enteral, parenteral covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UK clinical nutrition for cancer care market , including forecasts for subscribers. This country databook contains high-level insights into UK clinical nutrition for cancer care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account